VaramirStart free · no cardSign in
VRTX as of Oct 31 · 17:38 ET
VRTXNasdaqPharmaceutical Preparations

Vertex Pharmaceuticals Inc · Brief

Next report

2 days

Nov 2 · after closeconfirmedQ3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±5.2%
avg realized
±6.1%
Nov 4 '24±4.5%▲+5.73%×1.28
Feb 10 '25±4.5%▼−3.14%×0.70
May 5 '25±4.0%▼−10.03%×2.50
Aug 4 '25±5.6%▼−20.60%×3.65
Q3 FY25±6.0%▼−1.02%×0.17
Feb 12 '26±6.0%▲+5.69%×0.95
Q1 FY26±5.4%▼−1.28%×0.24
Q2 FY26±5.2%▲+1.70%×0.32
quarterimplied−25%0+25%realized×
Q2 FY26±5.2%▲+1.70%×0.32
Q1 FY26±5.4%▼−1.28%×0.24
Feb '26±6.0%▲+5.69%×0.95
Q3 FY25±6.0%▼−1.02%×0.17
Aug '25±5.6%▼−20.60%×3.65
May '25±4.0%▼−10.03%×2.50
2 older reports
Feb '25±4.5%▼−3.14%×0.70
Nov '24±4.5%▲+5.73%×1.28
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 2 report · confirmed

Bull2

10disclosed supplier and customer ties in SEC filings indicating broad commercial linksSEC filings
14tracked funds holding VRTXN-PORT · Aug 31 '26

Bear1

5 of 8recent reports where the move came in under the options-implied rangeEarnings history
AI captions · Sep 16 '26once per report · top 2 per case

Linked exposure

VRTX report session

Suppliers 3

EDITEditas Medicine×1.03CRSPCRISPR Therapeutics×0.64TRDAEntrada Therapeutics×0.57
× = co-movement · max 500dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 19impliedImplied move: ±5.7% into Nov 2 earnings (Oct 19 close).Source
Oct 7report dateEarnings date confirmed: Nov 2, after close.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.